How Artificial Intelligence Can Progress Organoid Intelligence Towards New Treatments

Artificial Intelligence (AI) is exponentially increasing the efficiency of the research and analysis towards discovery, formulation, optimization, and manufacturing. The language learning models through adaptive and generative learning models are benefiting the industry with ease of finding new and effective molecules, treatments for better patient care. The organoids have the functionality of an organ that could be used as a disease model in vitro. The application of AI (Example: brain organoid) can facilitate training neuronal cells for a specific output regarding their short and long memory patterns called ‘Organoid Intelligence’. The training of these organoids to produce a certain output of biomarkers or compounds can replicate a disease state identical to invivo model. Such models can be studied for new treatments that are not limited to either small molecules or complex treatment regimens for better outcomes and improved patient quality of life.